Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Recruiting 3Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Gynecologic 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 1Motor Activity 1Lung Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 45Paclitaxel 45Carboplatin 39Magnetic Resonance Spectroscopy 28olaparib 27Specimen Handling 26Cisplatin 24Bevacizumab 20Nivolumab 18Taxes 17Biopsy 16Gemcitabine 13Cyclophosphamide 13durvalumab 12Immunoglobulin G 11Doxorubicin 11Disulfides 11Surveys and Questionnaires 10niraparib 9liposomal doxorubicin 9dostarlimab 9Radiotherapy 8Brachytherapy 8lenvatinib 7fludarabine 7atezolizumab 7Letrozole 7Docetaxel 7cediranib 6Platinum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Control Groups × Gynecologic × Clear all
NCT02991677 2024-08-06

Exercise Effect on Chemotherapy-Induced Neuropathic Pain

Baltimore VA Medical Center

Phase NA Active not recruiting
60 enrolled
BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Motor Activity, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡